Axial spondyloarthritis and sarcoidosis are both inflammatory multi-system diseases. Having different pathophysiologies, they develop different typical lesions. The co-occurrence of both diseases is rare and nature of the association between the entities is unknown.
Introduction
Axial spondyloarthritis (SpA) is an inflammatory disease that predominantly affects vertebral and sacroiliac joint. Sarcoidosis is an inflammatory multi-system disease associated with the formation of non-caseating granulomas within involved systems (1) . Both diseases can involve ocular manifestations of which anterior uveitis are common feature. Articular involvement has been reported in about 5% of cases with sarcoidosis (2) . Therefore, it is sometimes difficult to distinguish one disease from the other. Sacroiliac joint involvement, in which the hallmark of axial SpA (3, 4) , is not a common feature of sarcoidosis. Here, we present a case with simultaneous onset of early axial SpA with ocular sarcoidosis.
Case Report
A 27-year-old woman was admitted to our ophthalmologic clinic with complaints of conjunctival injection and a pricking sense in both eyes for 2 months. Her medical history and familial history were unremarkable without constitutional symptoms, fever, weight loss, fatigue, arthralgia, myalgia and night sweating.
On the funduscopic examination, anterior chamber cell and perivascular sheathing were observed in both eyes. Furthermore, it showed peripheral vascular and disc leakage on fun- 
Discussion
Co-existence of axial SpA and sarcoidosis has been reported in only a small numbers of cases (5-7). Many of the cases were newly developed sarcoidosis in patients with advanced state of axial SpA. The difference with our case was a time of sarcoidosis development in which both diseases developed simultaneously in present case. Importantly, we had to differentiate two manifestations for proper diagnosis.
First, uveitis can develop in both diseases. It is critical which disease causes ocular symptoms that the patient complained.
When the two diseases are present at the same time, it is not easy to clarify whether one disease is the cause. Although up to a third can be asymptomatic, acute anterior uveitis is the most common presentation in sarcoidosis. Involvement is usu-ally bilateral, which distinguishes it from the unilateral uveitis seen in HLA-B27 associated spondyloarthropathies. Sarcoidosis can be presented by posterior uveitis including retinal vasculitis (8) . But, bilaterality and posterior uveitis are rare in axial SpA (9, 10) . Therefore, the ocular symptom in our patient may be caused by sarcoidosis.
Second, sacroiliitis may be presented with not only axial
SpA but sarcoidosis, due to sarcoid deposition (5). In a cross-sectional study, four of the sixty-one sarcoidosis patients (6.6%) had radiological erosive sacroiliitis (3). Relatively high sacroiliitis incidence in sarcoidosis group rather than general Although anti-tumor necrosis factor (TNF) therapy is helpful to axial SpA, it is controversial about effect to sarcoidosis.
Several studies have reported that de novo sarcoidosis can occur when treating patients with anti-TNF therapy (12, 13) . All three anti-TNF agents, etanercept, adalimumab and infliximab, have been observed to cause sarcoidosis-like granuloma formation, suggesting a 'class effect' rather than being drug specific (13) . On the other hand, it has been reported that anti-TNF therapy is effective for refractory sarcoidosis (14, 15) .
Summary
It has been reported that anti-TNF therapy may deteriorate disease course of sarcoidosis. If sarcoidosis develops in a patient treating anti-TNF therapy, cessation of the anti-TNF therapy and administration of steroid can induce a good response.
Until now, it is not worsen not only axial SpA but also sarcoidosis using anti-TNF antagonist. However, she is carefully supervised about both diseases.
